How Nanoparticles Interact with Cancer Cells
- 21 April 2015
- book chapter
- Published by Springer Nature
- Vol. 166, 227-244
Abstract
There are currently no nanoparticle formulations that optimally target diseased cells in the body. A small percentage of nanoparticles reach these cells and most accumulate in cells of the mononuclear phagocytic system. This chapter explores the interactions between nanoparticles and cells that may explain the causes for off-target accumulation of nanoparticles. A greater understanding of the nanoparticle-cellular interactions will lead to improvements in particle design for improved therapeutic outcome.Keywords
This publication has 68 references indexed in Scilit:
- The effect of sedimentation and diffusion on cellular uptake of gold nanoparticlesNature Nanotechnology, 2011
- The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayersNature Materials, 2011
- Surface Characteristics of Nanoparticles Determine Their Intracellular Fate in and Processing by Human Blood–Brain Barrier Endothelial Cells In VitroMolecular Therapy, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT ParticlesPharmaceutical Research, 2008
- Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexityHistochemistry and Cell Biology, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and ShapesNano Letters, 2007
- Cryo-electron Tomography of Clathrin-coated Vesicles: Structural Implications for Coat AssemblyJournal of Molecular Biology, 2007
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000